Absence of H2AX Gene Mutations in B-Cell Leukemias and Lymphomas

Leukemia - United Kingdom
doi 10.1038/sj.leu.2403651
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Cis-Regulatory Somatic Mutations and Gene-Expression Alteration in B-Cell Lymphomas

Genome Biology
2015English

Receptor-Directed Therapy of T-Cell Leukemias and Lymphomas

Journal of Immunotoxicology
ToxicologyImmunology
2008English

Cell Cycle Deregulation in B-Cell Lymphomas

Blood
BiochemistryImmunologyCell BiologyHematology
2003English

Surface Expression of BCL-2 in Chronic Lymphocytic Leukemia and Other B-Cell Leukemias and Lymphomas Without a Breakpoint T(14;18)

Molecular Medicine
Molecular MedicineGeneticsMolecular Biology
2008English

Double-Hit B-Cell Lymphomas

Blood
BiochemistryImmunologyCell BiologyHematology
2011English

Activating FLT3 Mutations in CD117/KIT+ T-Cell Acute Lymphoblastic Leukemias

Blood
BiochemistryImmunologyCell BiologyHematology
2004English

Lenalidomide in Diffuse Large B-Cell Lymphomas

Advances in Hematology
Hematology
2012English

BRAF Mutations in Acute Leukemias

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2003English

Using Gene Therapy to Manipulate the Immune System in the Fight Against B-Cell Leukemias

Expert Opinion on Biological Therapy
Drug DiscoveryClinical BiochemistryPharmacology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy